3 reasons to buy Nuplex Industries Ltd

Although its shares have underperformed of late, Nuplex Industries Ltd (ASX:NPX) could be a strong buy. Here's why.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the last year, global chemicals and construction product manufacturer Nuplex Industries Ltd (ASX: NPX) has seen its share price rise by as much as 20% before falling over the last three months so that it's now up only 1% since August 2013. This doesn't compare favourably to the ASX's performance, with the index being up 11% over the same time period. However, here's why Nuplex could prove to be a winning investment moving forward.

Super value

While many investors are understandably becoming rather nervous when it comes to share prices and their valuations, Nuplex seems to offer great value for money at its present price. For instance, shares in the chemicals company currently trade on a P/E of just 10.6, which is significantly below the ASX's P/E of 16.3. It's also less than the sector P/E of 13.1, which highlights Nuplex's relative value, as well as its absolute value at current price levels.

A top notch yield

As well as being cheap, shares in Nuplex also come with a great yield. Sure, it's unfranked, but a 7.4% yield still works out at a very respectable 4.1% on a tax adjusted basis. That's much higher than the current level of interest rates and, perhaps more importantly for income-seeking investors, Nuplex is forecast to increase dividends per share at a brisk pace over the next couple of years. Indeed, the company is expected to increase dividends per share by 8.6% in the next two years alone, which should maintain the company's present appeal as a top income play.

Growth potential

As well as being cheap and having a high yield, Nuplex could also have a bright future ahead of it. This is evidenced by growth forecasts over the next two years which show that the company's bottom line is set to rise by 15.2%, which is highly respectable and means that Nuplex could appeal to growth investors, as well as income and value investors.

Such high forecast growth rates mean that Nuplex trades on a PEG ratio of just 0.7, which shows just how potent the combination between growth and value (as well as income) could prove to be. As such, Nuplex could prove to be a great buy at current price levels.

Motley Fool contributor Peter Stephens does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »